TENNESSEE VALLEY AUTHORITY: Prescription for Growth
When Eli Lilly and Company in December 2025 announced plans to invest more than $6 billion in a new active pharmaceutical ingredient (API) manufacturing facility in Huntsville, Alabama, the project immediately rewrote the state’s record books, becoming the largest private capital investment in Alabama’s history.